Oppenheimer raised the firm’s price target on Live Nation (LYV) to $155 from $120 and keeps an Outperform rating on the shares after Q3 AOI grew +9% on Concert Margins expanding 232bps from Venue Nation generating a larger mix of high-margin ancillary revenues. The firm sees concert pipeline in large venues growing double digits, October ticket volume +23% year-over-year, and accelerating Sponsorships commitments, all serving as solid baseline for AOI continuing on similar double digits trajectory in 2025. Oppenheimer believes the new Republican administration will take a fresh look at the DOJ suit, with a higher likelihood of settling and extending the consent decree.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LYV:
- Live Nation price target raised to $145 from $108 at TD Cowen
- Live Nation price target raised to $144 from $132 at Benchmark
- Live Nation price target raised to $146 from $130 at Guggenheim
- Live Nation Reports Strong Q3 2024 Performance
- Closing Bell Movers: Live Nation jumps 6% after Q3 earnings beat